Quadcap Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Quadcap Wealth Management's BMY Position: Q2 2026 in Review
Quadcap Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 4.4% in Q2 2026, buying an estimated $46.9K and bringing the position to 19,394 shares worth $1.12M. The position accounts for 0.11% of the portfolio, ranked #166.
Quadcap Wealth Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.13M in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Quadcap Wealth Management held 19,394 shares of Bristol-Myers Squibb worth $1.12M as of Q2 2026.
- Quadcap Wealth Management bought 816 Bristol-Myers Squibb shares in Q2 2026, an estimated $46.9K.
- Bristol-Myers Squibb made up 0.11% of Quadcap Wealth Management's portfolio in Q2 2026, its #166 holding.
- Quadcap Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Quadcap Wealth Management's Bristol-Myers Squibb position peaked at $1.13M in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.